Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrhea

Gynecological Endocrinology

Volumn 13, Issue 2, 1999, Pages 89-92

  Laml, T ^a   Huber, J C ^a   Albrecht, A E ^a   Sintenis, W A ^b   Hartmann, B W ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b Specialist in Gynecol Psychother   (Germany)

Author keywords

Hormone replacement therapy; Pregnancy; Premature ovarian failure

Indexed keywords

ESTRADIOL VALERATE PLUS NORGESTREL; FOLLITROPIN; SEX HORMONE;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; ORAL DRUG ADMINISTRATION; OVARY DISEASE; PREGNANCY; PRIORITY JOURNAL;

EID: 0032983202     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599909167538     Document Type: Article

References (27)

1. 1. La Barbera, AR. Miller MM, Rebar RW. Auto-immune etiology in premature ovarian failure. Am J Reprod Immunol 1988;16:115-22
2. 2. Mehta AE, Matjiwiw I, Lyons EA, et al. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil Steril 1992;57:56-61
3. 3. Conway GS, Kaltsas G, Patel A, et al. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996;65:337-41
4. 4. Olivar AC. The role of laparoscopic ovarian biopsy in the management of premature gonadal failure. Conn Med 1996;60:707-8
5. 5. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-6
6. 6. O'Herlihy C, Peperell RJ, Evans JH. The significance of FSH elevation in young women with disorders of ovulation. Br Med J 1980;281: 1447-50
7. 7. Letur-Konirsch H, Guis F. Recovery of ovarian function after radiation-induced menopause. Does follicle-stimulating hormone (FSH) have a definitive prognostic value? C R Acad Sci III 1996;319: 907-12
8. 8. Rebar RW, Conolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:804-10
9. 9. Boyers SP, Luborsky JL, De Cherney AH. Usefulness of serial measurements of serum follicle stimulating hormone, luteinizing hormone and estradiol in patients with premature ovarian failure. Fertil Steril 1988;50:408-12
10. 10. Check JH, Chase JS, Spence M. Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy. Am J Obstet Gynecol 1989;160:114-15
11. 11. Aiman J, Smentek C. Premature ovarian failure. Obstet Gynecol 1985;66:9-14
12. 12. Check JH, Nowroozi K, Chase JS, et al. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:811-16
13. 13. Surrey ES, Cedars MI. The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertil Steril 1989; 52:36-47
14. 14. Nelson LM, Kimzey LM, White BJ, et al. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure. A controlled trial. Fertil Steril 1992;57:50-5
15. 15. Blumenfeld Z, el Halachmi S, Peretz BA, et al. Premature ovarian failure - the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 1993;59:750-5
16. 16. Richards JS, Ireland JJ, Rao MC, et al. Ovarian follicular development in the rat: hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone. Endocrinology 1976;99:1562-70
17. 17. Check JH, Wu CH, Check ML. The effect of leuprolide acetate in aiding induction of ovulation in hypergonadotropic hypogonadism: a case report. Fertil Steril 1988;49:542-3
18. 18. Betterle C, Rossi A, Dalla Pria S, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol 1993;39:35-43
19. 19. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 1985;9:23-4
20. 20. Damewood MD, Zacur HA, Hoffman GF, et al. Circulating anti-ovarian antibodies in premature ovarian failure. Obstet Gynecol 1986;68:850-4
21. 21. Luborsky JL, Visintin I, Boyers S, et al. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990;70:69-75
22. 22. Wheatcroft NJ, Toogood AA, Li TC, et al. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol 1994;96:122-8
23. 23. Fenichel P, Sosset C, Barbarino-Monnier P, et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod 1997;12:2623-8
24. 24. Hsueh AJ, Adashi EY, Jones PB, et al. Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocrinol Rev 1984;5:76-127
25. 25. Nimrod A, Lamprecht SA. Hormone-induced desensitization of cultured rat granulosa cells to FSH. Biochem Biophys Res Commun 1980;92: 905-11
26. 26. Goldenberg RL, Vaitukaitis JL, Ross GT. Estrogen and follicle stimulating hormone interactions on follicle growth in rats. Endocrinology 1972;90: 1492-8
27. 27. Anasti JN, Kalantaridou SN, Kimzey LM, et al. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1998;91:12-15